Search

Your search keyword '"Guri S. Sandhu"' showing total 7 results
Start Over Author "Guri S. Sandhu"
7 results on '"Guri S. Sandhu"'

1. Not Always Asthma: Clinical and Legal Consequences of Delayed Diagnosis of Laryngotracheal Stenosis

Author

Adam C. Nunn, S. Ali R. Nouraei, P. Jeremy George, Guri S. Sandhu, and S. A. Reza Nouraei

Subjects
Otorhinolaryngology, RF1-547
Abstract

Laryngotracheal stenosis (LTS) is a rare condition that occurs most commonly as a result of instrumentation of the airway but may also occur as a result of inflammatory conditions or idiopathically. Here, we present the case of a patient who developed LTS as a complication of granulomatosis with polyangiitis (GPA), which was misdiagnosed as asthma for 6 years. After an admission with respiratory symptoms that worsened to the extent that she required intubation, a previously well 14-year-old girl was diagnosed with GPA. Following immunosuppressive therapy, she made a good recovery and was discharged after 22 days. Over subsequent years, she developed dyspnoea and “wheeze” and a diagnosis of asthma was made. When she became pregnant, she was admitted to hospital with worsening respiratory symptoms, whereupon her “wheeze” was correctly identified as “stridor,” and subsequent investigations revealed a significant subglottic stenosis. The delay in diagnosis precluded the use of minimally invasive therapies, with the result that intermittent laser resection and open laryngotracheal reconstructive surgery were the only available treatment options. There were numerous points at which the correct diagnosis might have been made, either by proper interpretation of flow-volume loops or by calculation of the Empey or Expiratory Disproportion Indices from spirometry data.

Published
2014
Full Text
View/download PDF

2. Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5‐Year Update

Author

William S. Tierney, Li‐Ching Huang, Sheau‐Chiann Chen, Lynn D. Berry, Catherine Anderson, Milan R. Amin, Michael S. Benninger, Joel H. Blumin, Jonathan M. Bock, Paul C. Bryson, Paul F. Castellanos, Matthew S. Clary, Seth M. Cohen, Brianna K. Crawley, Seth H. Dailey, James J. Daniero, Alessandro de Alarcon, Donald T. Donovan, Eric S. Edell, Dale C. Ekbom, Daniel S. Fink, Ramon A. Franco, Catherine Gaelyn Garrett, Elizabeth A. Guardiani, Alexander T. Hillel, Henry T. Hoffman, Norman D. Hogikyan, Rebecca J. Howell, Michael M. Johns, Jan L. Kasperbauer, Sid M. Khosla, Cheryl Kinnard, Robbi A. Kupfer, Alexander J. Langerman, Robert J. Lentz, Robert R. Lorenz, David G. Lott, Samir S. Makani, Fabien Maldonado, Laura Matrka, Andrew J. McWhorter, Albert L. Merati, Matthew Mori, James L. Netterville, Karla O'Dell, Julina Ongkasuwan, Gregory N. Postma, Lindsay S. Reder, Sarah L. Rohde, Brent E. Richardson, Otis B. Rickman, Clark A. Rosen, Matthew Rohlfing, Michael J. Rutter, Guri S. Sandhu, Joshua S. Schindler, Glenn Todd Schneider, Rupali N. Shah, Andrew G. Sikora, Robert J. Sinard, Marshall E. Smith, Libby J. Smith, Ahmed M. S. Soliman, Sigríður Sveinsdóttir, David Veivers, Sunil P. Verma, Paul M. Weinberger, Philip A. Weissbrod, Christopher T. Wootten, Yu Shyr, David O. Francis, and Alexander Gelbard

Subjects
Otorhinolaryngology, Surgery
Published
2023

3. Informed consent for suspension microlaryngoscopy: what should we tell the patient? A consensus statement of the European Laryngological Society

Author

Frederik G. Dikkers, Michel R. M. San Giorgi, Rico N. P. M. Rinkel, Marc Remacle, Antoine Giovanni, Małgorzata Wierzbicka, Riaz Seedat, Guillermo Campos, Guri S. Sandhu, Otolaryngology / Head & Neck Surgery, CCA - Cancer Treatment and quality of life, Ear, Nose and Throat, and APH - Quality of Care

Subjects
Benign laryngeal pathology, Elective suspension microlaryngoscopy, Consensus, Laryngoscopy, Consent discussion, General Medicine, Quality modern health service, Phonosurgery, Europe, Otorhinolaryngology, Humans, Health care provider, Informed consent, Societies, Medical, Shared decision-making, Consent process
Abstract

Introduction Informed consent for any surgical intervention is necessary, as only well-informed patients can actively participate in the decision-making process about their care, and better understand the likely or potential outcomes of their treatment. No consensus exists on informed consent for suspension microlaryngoscopy (SML). Materials and methods Informed consent procedures in nine countries on five continents were studied. Results Several risks can be discerned: risks of SML as procedure, anesthesiologic risks of SML, specific risks of phonosurgery, risks of inadequate glottic exposure or unexpected findings, risks of not treating. SML has recognized potential complications, that can be divided in temporary (minor) complications, and lasting (major) complications. Conclusion SML is a safe procedure with low morbidity, and virtually no mortality. Eleven recommendations are provided.

Published
2022

4. Abstract 16929: Propensity-matched Analysis of Triple Oral Antithrombotic Therapy versus Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention

Author

David R. Holmes, Verghese Mathew, Kent R. Bailey, Ryan J. Lennon, Daniel B. Spoon, Joshua P. Slusser, Charanjit S. Rihal, Robert D. McBane, Guri S Sandhu, and Rajiv Gulati

Subjects
medicine.medical_specialty, Aspirin, business.industry, medicine.medical_treatment, Warfarin, Percutaneous coronary intervention, Clopidogrel, Optimal management, Increased risk, Physiology (medical), Internal medicine, Propensity score matching, Antithrombotic, medicine, Cardiology, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

Introduction: Triple oral antithrombotic therapy (TOAT) (aspirin, clopidogrel, and warfarin) is associated with an increased risk of bleeding. Despite this, the optimal management of patients with indications for warfarin following percutaneous coronary intervention (PCI) has not been established. We sought to compare long-term clinical outcomes between patients receiving TOAT with those receiving dual antiplatelet therapy (DAPT) (aspirin and clopidogrel) after PCI. Hypothesis: Patients with clinical indications for warfarin have higher baseline risk which is largely responsible for the observed differences in outcomes between patients receiving TOAT vs. DAPT. Methods: Retrospective analysis of prospectively collected data from 9,009 patients. The primary outcome was a composite of all-cause mortality, ischemic or embolic events (myocardial infarction or stroke), or bleeding. Secondary outcomes were death plus ischemic or embolic events, death plus bleeding, death, MI, stroke, and bleeding. A 2:1 propensity matched analysis was also performed. Results: In 9,009 patients, 812 received TOAT and 8,197 received DAPT. Median follow-up was 61 months. The primary end point occurred in 2,749 patients. At 1 year, 22% of patients treated with TOAT had the primary endpoint versus 11% of DAPT patients (p Conclusions: In a large single center registry with comprehensive follow up, patients treated with TOAT had higher rates of ischemic and bleeding events. However, when baseline risks are accounted for event rates are similar, other than minor bleeding, indicating patient risk characteristics are largely responsible for the observed differences in outcomes.

Published
2015

5. Accelerated Coronary Plaque Progression and Endothelial Dysfunction

Author

Charanjit S. Rihal, Martin Reriani, Guri S Sandhu, Erik Eeckhout, Mario Gössl, Ryan J. Lennon, Myeong Ho Yoon, Amir Lerman, Lilach O. Lerman, Jonella M Tilford, Rajiv Gulati, and Byoung Jwoo Choi

Subjects
medicine.medical_specialty, Systemic disease, Pathology, business.industry, Plaque progression, 030204 cardiovascular system & hematology, medicine.disease, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, medicine.anatomical_structure, Text mining, Radiology Nuclear Medicine and imaging, Coronary plaque, Internal medicine, medicine, Cardiology, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Endothelial dysfunction, Cardiology and Cardiovascular Medicine, business, Artery
Abstract

Although atherosclerosis is a systemic disease, plaque progression and complications occur in a focal, patchy pattern. It remains challenging to predict which segments of a given coronary artery will show accelerated progression of atherosclerosis. Coronary endothelial dysfunction, characterized by

Published
2014

6. Contributors

Author

Waleed M. Abuzeid, Meredith E. Adams, Peter A. Adamson, Antoine Adenis, Seth Akst, Sheri L. Albers, David Albert, Ronda E. Alexander, Sue Archbold, William B. Armstrong, Moisés A. Arriaga, H. Alexander Arts, Yasmine A. Ashram, Jonathan E. Aviv, Nafi Aygun, Douglas D. Backous, Shan R. Baker, Thomas J. Balkany, Robert W. Baloh, Julie Barkmeier-Kraemer, Fuad M. Baroody, Nancy L. Bartlett, Jonathan Z. Baskin, Robert W. Bastian, Carol A. Bauer, Michael S. Benninger, Prabhat K. Bhama, Nasir Islam Bhatti, Andrew Blitzer, Simone Boardman, Emily F. Boss, Derald E. Brackmann, Carol R. Bradford, Barton F. Branstetter, Edward B. Braun, Robert J.S. Briggs, Hilary A. Brodie, Carolyn J. Brown, David J. Brown, Kevin D. Brown, J. Dale Browne, John M. Buatti, Luke Buchmann, Patrick J. Byrne, Gabriel G. Galzada, John P. Carey, Margaretha L. Casselbrant, Paolo Castelnuovo, Steven Chang, Burke E. Chegar, Amy Chen, Eunice Y. Chen, Theodore Chen, Douglas B. Chepeha, Alice Cheuk, Neil N. Chheda, Wade Chien, Sukgi S. Choi, Richard A. Chole, James M. Christian, Eugene A. Chu, Martin J. Citardi, Marc A. Cohen, Savita Collins, Nancy A. Collop, Philippe Contencin, Raymond Cook, Jacquelynne Corey, Robin T. Cotton, Marion Everett Couch, Mark S. Courey, Benjamin T. Crane, Roger L. Crumley, Oswaldo Laércio M. Cruz, Frank Culicchia, Charles W. Cummings, Calhoun D. Cunningham, Greg E. Davis, Larry E. Davis, Terry A. Day, Antonio De la Cruz, Charles C. Della Santina, Chadrick Denlinger, Craig S. Derkay, Rodney C. Diaz, Robert A. Dobie, Suzanne K. Doud Galli, Newton O. Duncan, Scott D.Z. Eggers, Avraham Eisbruch, David W. Eisele, Hussam K. El-Kashlan, Ravindhra G. Elluru, Kevin H. Ende, Audrey B. Erman, Samer Fakhri, Carole Fakhry, Edward H. Farrior, Richard T. Farrior, Russell A. Faust, Berrylin J. Ferguson, Paul W. Flint, Howard W. Francis, Marvin P. Fried, David R. Friedland, Oren Friedman, John L. Frodel, Gerry F. Funk, Bruce J. Gantz, C. Gaelyn Garrett, Jackie Gartner-Schmidt, William Donald Gay, Norman N. Ge, M. Boyd Gillespie, Douglas A. Girod, George S. Goding, Andrew N. Goldberg, David Goldenberg, Daniel O. Graney, Nazaneen N. Grant, Vincent Grégoire, Heike Gries, Samuel P. Gubbels, Joel Guss, Patrick Ha, Grant S. Hamilton, Ehab Y. Hanna, Lee A. Harker, Uli Harréus, Robert V. Harrison, Bruce H. Haughey, John W. Hellstein, Kurt Herzer, Michael S. Hildebrand, Frans J.M. Hilgers, Justin D. Hill, Michael L. Hinni, Henry T. Hoffman, Eric H. Holbrook, Lauren D. Holinger, Allison MacGregor Holzapfel, David B. Hom, John W. House, Joyce Colton House, Timothy E. Hullar, Murad Husein, Steven Ing, Tim A. Iseli, Stacey Ishman, Robert K. Jackler, Brian Jameson, Herman A. Jenkins, Hong-Ryol Jin, John K. Joe, Stephanie A. Joe, Gary Johnson, Rhonda Johnson, Tiffany A. Johnson, Timothy M. Johnson, Nick S. Jones, Sheldon S. Kabaker, Lucy H. Karnell, Matthew L. Kashima, Robert M. Kellman, Paul E. Kelly, David W. Kennedy, Ayesha N. Khalid, Merrill S. Kies, Paul R. Kileny, David W. Kim, Jason H. Kim, Theresa B. Kim, William J. Kimberling, Jeffrey Koh, Niels Kokot, Peter J. Koltai, Frederick K. Kozak, Paul R. Krakovitz, Russell W.H. Kridel, Parvesh Kumar, Melda Kunduk, Ollivier Laccourreye, JoAnne Lacey, Stephen Y. Lai, Devyani Lal, Anil K. Lalwani, Paul R. Lambert, Amy Anne Lassig, Richard E. Latchaw, Kevin P. Leahy, Daniel J. Lee, Ken K. Lee, Nancy Lee, Jean-Louis Lefebvre, Maureen A. Lefton-Greif, Donald A. Leopold, James S. Lewis, Daqing Li, Timothy S. Lian, Greg R. Licameli, Charles J. Limb, Jeri A. Logemann, Thomas Loh, Brenda L. Lonsbury-Martin, Manuel A. Lopez, Rodney P. Lusk, Lawrence R. Lustig, Anna Lysakowski, Carol J. MacArthur, Robert H. Maisel, James P. Malone, Ellen M. Mandel, Susan J. Mandel, Scott C. Manning, Lynette Mark, Jeffery C. Markt, Michael Marsh, Glen K. Martin, Douglas E. Mattox, Thomas V. McCaffrey, Timothy M. McCulloch, JoAnn McGee, John F. McGuire, Jonathan McJunkin, J. Scott McMurray, Albert L. Merati, Saumil N. Merchant, Anna H. Messner, James Michelson, Henry A. Milczuk, Lloyd B. Minor, Steven Ross Mobley, Harlan Muntz, Craig S. Murakami, Charles M. Myer, Robert M. Naclerio, Joseph B. Nadol, Paul S. Nassif, Julian Nedzelski, Piero Nicolai, David R. Nielsen, John K. Niparko, Susan J. Norton, S.A. Reza Nouraei, Daniel W. Nuss, Brian Nussenbaum, Rick M. Odland, Gerard O'Donoghue, Eric R. Oliver, Bert W. O’Malley, Robert C. O’Reilly, Juan Camilo Ospina, Robert H. Ossoff, Kristen J. Otto, Mark D. Packer, John Pallanch, James N. Palmer, Stephen S. Park, Sundip Patel, G. Alexander Patterson, Bruce W. Pearson, Phillip K. Pellitteri, Jonathan A. Perkins, Stephen W. Perkins, Colin D. Pero, Shirley S.N. Pignatari, Steven D. Pletcher, Aron Popovtzer, Gregory N. Postma, William P. Potsic, Sheri A. Poznanovic, Vito C. Quatela, C. Rose Rabinov, Virginia Ramachandran, Gregory W. Randolph, Christopher H. Rassekh, Steven D. Rauch, Lou Reinisch, Mark, A. Richardson, Gresham T. Richter, James M. Ridgway, K. Thomas Robbins, Frederick C. Roediger, Jeremy Rogers, Ohad Ronen, Richard M. Rosenfeld, Bruce E. Rotter, Jay T. Rubinstein, Michael J. Ruckenstein, Zoran Rumboldt, Christina L. Runge-Samuelson, Leonard P. Rybak, Babak Sadoughi, John R. Salassa, Thomas J. Salinas, Sandeep Samant, Robin A. Samlan, Ravi N. Samy, Henry D. Sandel, Guri S. Sandhu, Isamu Sando, Cara Sauder, Jeremy A. Scarlett, Richard L. Scher, David A. Schessel, Cecelia E. Schmalbach, Todd J. Schwedt, James J. Sciubba, Sunitha Sequeira, Meena Seshamani, Clough Shelton, Neil T. Shepard, Jonathan A. Ship, W. Peyton Shirley, Yelizaveta Shnayder, Joseph Shvidler, Kathleen C.Y. Sie, Daniel B. Simmen, Marshall E. Smith, Richard J.H. Smith, Robert A. Sofferman, Marlene Soma, Brad A. Stach, Hinrich Staecker, Aldo Cassol Stamm, James A. Stankiewicz, Rose Stavinoha, Laura M. Sterni, David L. Steward, Rose Mary S. Stocks, Holger H. Sudhoff, John B. Sunwoo, Neil A. Swanson, Veronica C. Swanson, Robert A. Swarm, Jonathan M. Sykes, Luke Tan, M. Eugene Tardy, Sherard A. Tatum, S. Mark Taylor, Natacha Teissier, Steven A. Telian, David J. Terris, Karen B. Teufert, J. Regan Thomas, James N. Thompson, Dean M. Toriumi, Alejandro I. Torres, Joseph B. Travers, Susan P. Travers, Terance T. Tsue, Ralph P. Tufano, David E. Tunkel, Michael D. Turner, Ravindra Uppaluri, Michael F. Vaezi, Thierry Van den Abbeele, Michiel W.M. van den Brekel, Mikhail Vaysberg, David E. Vokes, P. Ashley Wackym, Tamekia L. Wakefield, David L. Walner, Edward J. Walsh, Rohan R. Walvekar, Tom D. Wang, Frank M. Warren, Randal S. Weber, Richard O. Wein, Gregory S. Weinstein, Erik Kent Weitzel, D. Bradley Welling, Richard D. Wemer, Ralph F. Wetmore, Ernest A. Weymuller, Brian J. Wiatrak, Gregory J. Wiet, Richard H. Wiggins, Andrea Willey, William N. William, Glenn B. Williams, Franz J. Wippold, Gayle Ellen Woodson, Audie L. Woolley, Christopher T. Wootten, Peter-John Wormald, Charles D. Yingling, Bevan Yueh, Rex C. Yung, Renzo A. Zaldívar, George H. Zalzal, David S. Zee, Marc S. Zimbler, S. James Zinreich, and Teresa A. Zwolan

Published
2010

7. Incidence and significance of myocardial injury after surgical treatment of head and neck cancer

Author

S A Reza, Nouraei, Chadwan, Al-Yaghchi, Guri S, Sandhu, Dino A, Giussani, Patrick, Doyle, and Peter M, Clarke

Subjects
Male, Postoperative Care, Incidence, Myocardial Infarction, Middle Aged, Prognosis, Troponin, Cohort Studies, C-Reactive Protein, Postoperative Complications, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Humans, Neck Dissection, Female
Abstract

To review the incidence of, and risk factors for myocardial injury after head and neck surgery to help optimize patient care and develop perioperative cardioprotective strategies.Observational cohort study.Records of 65 patients surgically treated for upper aerodigestive tract squamous cell carcinoma between 2005 and 2006 were reviewed. Information about cardiovascular history, tumor characteristics, details of surgery, and postoperative complications were recorded. Patients had troponin assays on the third postoperative day. Logistic regression was used to identify risk factors for postoperative myocardial injury.The average age at presentation was 62+/-12 years. There were 46 (71%) males and 19 (29%) females. Troponin-positive and -negative groups were matched for age, sex, cardiovascular risks, comorbidity, site, tumor-node-metastasis status, and duration of the operations. Sixteen (25%) patients had postoperative myocardial injury including five clinical myocardial infarctions. Factors identified as independent predictors of postoperative myocardial injury were blood pressure level (odds ratio [OR] 1.17; 95% confidence interval [CI] 1.04-1.31; P.02), intraoperative heart rate variability (OR 1.33; 95% CI 1.04-1.71; P.02), and the degree of postoperative inflammatory response (OR 1.07; 95% CI 1.02-1.13; P.001).Postoperative myocardial injury is a known independent predictor of cardiovascular prognosis. Its incidence in head and neck patients could potentially be reduced through stringent blood pressure management, tight intraoperative heart rate control, and dampening of the postoperative inflammatory response. Troponin testing is a valuable screening tool, and patients who have elevated levels postoperatively should be closely monitored and referred to a cardiologist for optimization of cardiovascular care.

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results